L-.GAMMA.-GLUTAMYL-S-((1R)-2-(((4R)-5,6-DIFLUORO-1,2,3,4-TETRAHYDRO-2-OXO-4-(TRIFLUOROMETHYL)-4-QUINAZOLINYL)CARBONYL)CYCLOBUTYL)-L-CYSTEINYL-GLYCINE
UNII QI7QG3MJB4
Substance Identification & Data
This profile provides standardized clinical and technical data for L-.gamma.-glutamyl-s-((1r)-2-(((4r)-5,6-difluoro-1,2,3,4-tetrahydro-2-oxo-4-(trifluoromethyl)-4-quinazolinyl)carbonyl)cyclobutyl)-l-cysteinyl-glycine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QI7QG3MJB4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 410090-41-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H26F5N5O8S MBKLQTOJPQWYFI-ABETYJBWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for L-.gamma.-glutamyl-s-((1r)-2-(((4r)-5,6-difluoro-1,2,3,4-tetrahydro-2-oxo-4-(trifluoromethyl)-4-quinazolinyl)carbonyl)cyclobutyl)-l-cysteinyl-glycine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.